Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

Clinical Trial Site, Sarasota, Florida, United States

Clinical Trial Site, Tamarac, Florida, United States

Clinical Trial Site, Baltimore, Maryland, United States

Clinical Trial Site, Boston, Massachusetts, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, Leland, North Carolina, United States

Clinical Trial Site, Cincinnati, Ohio, United States

Clinical Trial Site, Cleveland, Ohio, United States

Clinical Trial Site, Columbus, Ohio, United States

Clinical Trial Site, Pittsburgh, Pennsylvania, United States

Clinical Trial Site, Dallas, Texas, United States

Clinical Trial Site, Edinburg, Texas, United States

Clinical Trial Site, Morgantown, West Virginia, United States